Holiday pricing through Dec 25, 2026: 20% off single-grant packages, 25% off annual programs. See pricing

Serving clients in the US, UK and Australia+1 (844) 400-0525

US grant · National Institutes of Health

High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional)

Up to $1,500,000 Closes March 5, 2027

Official listing and how to apply Full funding notice

Source: Grants.gov · Last checked

Key facts

FunderNational Institutes of Health
Part ofDepartment of Health and Human Services
Opportunity numberRFA-DA-25-060
Amount per awardUp to $1,500,000
OpensJanuary 17, 2024
ClosesMarch 5, 2027 (115 days left)
Who can applySchools and universities, Businesses, Government, Nonprofits, Other (see listing), Tribal organizations
Applicant types listedNative American tribal governments (Federally recognized); Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education; Small businesses; Public and State controlled institutions of higher education; Private institutions of higher education; County governments; Special district governments; Others (see text field entitled "Additional Information on Eligibility" for clarification); Independent school districts; For profit organizations other than small businesses; Native American tribal organizations (other than Federally recognized tribal governments); State governments; City or township governments; Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education; Public housing authorities/Indian housing authorities
State or areaNationwide
Cost sharing or matchNot required
StatusOpen
SourceGrants.gov
Last checkedNovember 10, 2026

About this grant

Summary from the official listing on Grants.gov:

The purpose of this Funding Opportunity Announcement (FOA) is to support high priority research at the intersection of HIV and substance use. This FOA invites innovative research projects with the potential to open new areas of HIV/AIDS research and/or lead to new avenues for prevention, treatment and cure of HIV among people who use drugs (PWUD). Applications submitted under this FOA are required to have a detailed research plan, preliminary data, and a clear description of the nexus with substance use. This FOA is open to both individual researchers and research teams and includes all areas of research from basic science to clinical and implementation research. All studies must focus on NIH HIV/AIDS Research Priorities: NOT-OD-20-018: UPDATE: NIH HIV/AIDS Research Priorities and Guidelines for Determining HIV/AIDS Funding.

Eligibility

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Details are copied from the official source and can change. Check the official listing before you apply. Grant Writing Company is not affiliated with this funder.

Want an expert to write it with you?

Grant Writing Company researches funders, writes organization proposals to each funder's instructions, and checks the package before you submit. experience since 2006. Funders decide every award.

Book a free call See our services